An interventional study of Plant-Based Diet and General Diet in Healthy and Dietary Habits, sponsored by Tzu Chi University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by Tzu Chi University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this pilot randomized crossover feasibility trial is to determine the feasibility of a short-term, culture-tailored, plant-based dietary behavior intervention and examine the preliminary outcomes regarding inflammation and metabolic markers in generally healthy adults. The main questions it aimed to answer were:
Are the trial design and corresponding outcomes, including recruitment rate, retention rate, meal delivery completion, participant satisfaction, and adverse event occurrence feasible for a future definitive study? Are the clinical outcomes were examined as preliminary secondary endpoints able to generate effect size estimates for future study planning?
Participants were:
Randomly allocated to group PBD (plant-based diet)-GD (general diet) or group GD-PBD. Group PBD-GD completed the 2-week PBD stage first, crossed over after the 1-week washout period, then completed the 2-week GD stage. Group GD-PBD followed the reverse sequence.
Instructed to record their daily dietary intake throughout both stages in a mobile food diary application.
Invited to visit the trial venue for the measurements at four time points: before and after each stage.
Background Despite growing evidence for PBD's anti-inflammatory effects, few studies have examined its feasibility and short-term efficacy within a culturally specific, real-world dietary context, particularly in East Asian populations. The current pilot randomized crossover feasibility trial aimed to determine the feasibility of a short-term, culture-tailored, and plant-based dietary behavior intervention and its preliminary outcomes regarding inflammation and metabolic markers.
Methods The randomized, single-blinded crossover feasibility trial was conducted at a regional general hospital in eastern Taiwan. Participants were randomly allocated to group PBD-GD or group GD-PBD using a computer-generated random number sequence. After 2-week intervention followed by 1-week washout period, participants were crossed over to the other group for the subsequent 2-week intervention. During the dietary intervention, lunch and dinner were provided by local commercial restaurants during weekdays based on assigned stage. Primary outcome, high-sensitivity C-reactive protein (Hs-CRP), along with the secondary outcomes, interleukin-6 (IL-6), IL-10, low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and triglycerides (TG) were measured before and after each intervention, at week 0, 2, 3, and 4. Adherence was supported through two platforms, an anonymous group messaging platform and a mobile food diary application.
988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.
This study's enrollment of 30 is below the median of 79 across 700 interventional studies indexed under Feeding Behavior.
Browse Feeding Behavior studies →Tzu Chi University is the lead sponsor of 20 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group PBD-GD completed the 2-week PBD stage first, crossed over after the washout period, then completed the 2-week GD stage.
Other: Plant-Based Diet · Other: General Diet
Group GD-PBD completed the 2-week GD stage first, crossed over after the washout period, then completed the 2-week PBD stage
Other: Plant-Based Diet · Other: General Diet
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
Retention rate (%)
The number of participants included in the final analysis divided by the total number of participants enrolled
Time frame: At week 0 and week 5
Meal Delivery Completion Rate (%)
The number of meal deliveries received within the designated time window divided by the total number of scheduled meal deliveries across the intervention period
Time frame: Period of Meal Provision, at week 1-2 and week 4-5
Satisfaction score (mean score)
A score of 3.0 of each item on a 5-point Likert scale was utilized as the minimal criterion for acceptability
Time frame: At each post-stage timepoint, week 2 and week 5
Adverse Events (event count)
Particular attention to food safety and the individual tolerability of the dietary changes
Time frame: Throughout the intervention periond, from week 1 to week 5
High-sensitivity C-reactive protein (Hs-CRP, mg/L)
Physiological Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Interleukin-6 (IL-6, pg/mL)
Physiological Pro-Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Interleukin-10 (IL-10, pg/mL)
Physiological Anti-Inflammatory Indicator
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Complete Blood Counts
WBC (10³/µL), RBC(10³/µL), Hgb (g/dL), HCT (%), and PLT (10³/µL)
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Fasting blood sugar (FBS, mg/dL) and Lipo-Profiles
Fasting blood sugar (FBS, mg/dL) and lipid profiles, including high-density lipoprotein cholesterol (HDL-C, mg/dL), low-density lipoprotein cholesterol (LDL-C, mg/dL), and triglycerides (TG, mg/dL)
Time frame: Before and After each Stage, at Week 1, 2, 4, and 5
Plan to share: No
Ran from Jun 2023 to primary completion in Sep 2023, 3 months.
Of 503 non-industry interventional studies with no phase under Feeding Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 3 months is below that.
Counting every sponsor, half of 515 studies reached it within 14 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tzu Chi University